The carnage in the biotech space in Q4 of last year was devastating to a lot of portfolios, and many of the stocks in the space became victims of aggressive tax-loss selling before year end to add insult to injury. But, rejoice, dear investor! That just means we have some great values lying around on […]
CLVS
Sarepta Therapeutics’ Eteplirsen Study Reveals Benefits to Patients (SRPT)
Sarepta Therapeutics (NASDAQ: SRPT), an RNA-based therapeutics company that develops drugs to treat serious, life-threatening, rare and infectious diseases, announced at the Action Duchenne meeting in London that patients treated with eteplirsen continue to do well. Benefits to Patients Sarepta’s Chief Medical Officer, Dr. Ed Kaye, was speaking about the results from the phase II […]
Recent Stories
Twitter Inc (NYSE:TWTR) Strikes Grindr Out Of Its Ad Network After Failing To Adhere To Regulations
Toyota Recalls Over 700,00o Toyota and Lexus Vehicles Because of A faulty Fuel Pump
Visa Inc (NYSE:V) Spends $5.3 Billion To Acquire Silicon Valley Start-up – Plaid
Ford Motors Company’s (NYSE:F) Report 26.1% Decline In 2019’s Vehicle Sales in China
Verizon Communications Inc. (NYSE:VZ) Separates TV And Internet Plans To Retain Subscribers Of Traditional Cable TV